The prevalence of XDR Shigella isolates in US surveillance data rose from 0% during 2011-2015 to 8.5% in 2023.
Syphilis cases in the Seattle area fell by 52% overall after the intervention was implemented, but no effect was seen on congenital syphilis.
The CDC and FDA continue to investigate the E coli outbreak, which has sickened 9 people in 3 states.
Complementary efforts, such as those that facilitate clinician adherence and ensure patient access to and treatment completion, would likely be needed for sustained impact.
Among gay and bisexual men with a history of gonorrhea infection who received either the 4CMenB vaccine or placebo, gonorrhea incidence was essentially the same—roughly 48% in both arms.
State health officials have identified 13 confirmed and 27 suspected cases of Trichophyton mentagrophytes type VII, a fungal skin infection that causes severe ringworm.
The increase follows a previously documented 222% surge from 2016 to 2022.
The European health agency says decisions on doxycycline post-exposure prophylaxis use should be made at the individual level, following clinical judgement and national guidelines.
Reduced funding will erode decades of progress and impede future advancements, but there is hope for the future with alternative resources.
Debio1453 is a first-in-class antibiotic candidate that targets an enzyme that’s essential for the growth of Neisseria gonorrhoeae.
